The Effects of Immunosuppressive and Cytotoxic Drugs on the Heart

Stuart D. Russell

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Antiinflammatory therapy is the principal therapy for most rheumatic diseases with the primary therapeutic goal being to reduce the destructive effects of the inflammatory process without causing systemic side effects due to overimmunosuppression. The heart is one of the primary organs affected by the side effects of these agents through both direct (myocardial injury) and indirect (hypertension, hyperlipidemia, etc.) actions that can result in myocardial injury in a number of different ways. Cyclophosphamide has direct cardiotoxic effects and can result in heart failure. Prednisone has secondary side effects including hypertension and hyperlipidemia, which can cause and/or accelerate coronary artery disease, and if a myocardial infarction happens can result in heart failure due to ischemic injury. Conversely, prednisone and other agents are often used for the therapy of inflammatory processes of the heart and in that setting can actually preserve left ventricular function and result in an improvement in ejection fraction. Finally, cyclosporine, which was the principal immunosuppressive agent responsible for the vast increase in organ transplantation, has resulted in many patients undergoing heart transplantation safely that otherwise would never have received a heart. This chapter will review the positive and negative cardiac properties of the traditional antiinflammatory agents prednisone, azathioprine, methotrexate, cyclosporine, and cyclophosphamide.

Original languageEnglish (US)
Title of host publicationThe Heart in Rheumatic, Autoimmune and Inflammatory Diseases
Subtitle of host publicationPathophysiology, Clinical Aspects and Therapeutic Approaches
PublisherElsevier Inc.
Pages645-657
Number of pages13
ISBN (Electronic)9780128032688
ISBN (Print)9780128032671
DOIs
StatePublished - Feb 22 2017

Fingerprint

Immunosuppressive Agents
Prednisone
Hyperlipidemias
Pharmaceutical Preparations
Cyclophosphamide
Cyclosporine
Wounds and Injuries
Anti-Inflammatory Agents
Heart Failure
Hypertension
Azathioprine
Organ Transplantation
Heart Transplantation
Therapeutics
Rheumatic Diseases
Left Ventricular Function
Methotrexate
Coronary Artery Disease
Myocardial Infarction

Keywords

  • Cardiovascular disease
  • Immunosuppressive therapy
  • Inflammation
  • Myocarditis
  • Side effects

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Russell, S. D. (2017). The Effects of Immunosuppressive and Cytotoxic Drugs on the Heart. In The Heart in Rheumatic, Autoimmune and Inflammatory Diseases: Pathophysiology, Clinical Aspects and Therapeutic Approaches (pp. 645-657). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-803267-1.00026-0

The Effects of Immunosuppressive and Cytotoxic Drugs on the Heart. / Russell, Stuart D.

The Heart in Rheumatic, Autoimmune and Inflammatory Diseases: Pathophysiology, Clinical Aspects and Therapeutic Approaches. Elsevier Inc., 2017. p. 645-657.

Research output: Chapter in Book/Report/Conference proceedingChapter

Russell, SD 2017, The Effects of Immunosuppressive and Cytotoxic Drugs on the Heart. in The Heart in Rheumatic, Autoimmune and Inflammatory Diseases: Pathophysiology, Clinical Aspects and Therapeutic Approaches. Elsevier Inc., pp. 645-657. https://doi.org/10.1016/B978-0-12-803267-1.00026-0
Russell SD. The Effects of Immunosuppressive and Cytotoxic Drugs on the Heart. In The Heart in Rheumatic, Autoimmune and Inflammatory Diseases: Pathophysiology, Clinical Aspects and Therapeutic Approaches. Elsevier Inc. 2017. p. 645-657 https://doi.org/10.1016/B978-0-12-803267-1.00026-0
Russell, Stuart D. / The Effects of Immunosuppressive and Cytotoxic Drugs on the Heart. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases: Pathophysiology, Clinical Aspects and Therapeutic Approaches. Elsevier Inc., 2017. pp. 645-657
@inbook{2d7d9330352749b1aa050fea2e573e4e,
title = "The Effects of Immunosuppressive and Cytotoxic Drugs on the Heart",
abstract = "Antiinflammatory therapy is the principal therapy for most rheumatic diseases with the primary therapeutic goal being to reduce the destructive effects of the inflammatory process without causing systemic side effects due to overimmunosuppression. The heart is one of the primary organs affected by the side effects of these agents through both direct (myocardial injury) and indirect (hypertension, hyperlipidemia, etc.) actions that can result in myocardial injury in a number of different ways. Cyclophosphamide has direct cardiotoxic effects and can result in heart failure. Prednisone has secondary side effects including hypertension and hyperlipidemia, which can cause and/or accelerate coronary artery disease, and if a myocardial infarction happens can result in heart failure due to ischemic injury. Conversely, prednisone and other agents are often used for the therapy of inflammatory processes of the heart and in that setting can actually preserve left ventricular function and result in an improvement in ejection fraction. Finally, cyclosporine, which was the principal immunosuppressive agent responsible for the vast increase in organ transplantation, has resulted in many patients undergoing heart transplantation safely that otherwise would never have received a heart. This chapter will review the positive and negative cardiac properties of the traditional antiinflammatory agents prednisone, azathioprine, methotrexate, cyclosporine, and cyclophosphamide.",
keywords = "Cardiovascular disease, Immunosuppressive therapy, Inflammation, Myocarditis, Side effects",
author = "Russell, {Stuart D.}",
year = "2017",
month = "2",
day = "22",
doi = "10.1016/B978-0-12-803267-1.00026-0",
language = "English (US)",
isbn = "9780128032671",
pages = "645--657",
booktitle = "The Heart in Rheumatic, Autoimmune and Inflammatory Diseases",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - The Effects of Immunosuppressive and Cytotoxic Drugs on the Heart

AU - Russell, Stuart D.

PY - 2017/2/22

Y1 - 2017/2/22

N2 - Antiinflammatory therapy is the principal therapy for most rheumatic diseases with the primary therapeutic goal being to reduce the destructive effects of the inflammatory process without causing systemic side effects due to overimmunosuppression. The heart is one of the primary organs affected by the side effects of these agents through both direct (myocardial injury) and indirect (hypertension, hyperlipidemia, etc.) actions that can result in myocardial injury in a number of different ways. Cyclophosphamide has direct cardiotoxic effects and can result in heart failure. Prednisone has secondary side effects including hypertension and hyperlipidemia, which can cause and/or accelerate coronary artery disease, and if a myocardial infarction happens can result in heart failure due to ischemic injury. Conversely, prednisone and other agents are often used for the therapy of inflammatory processes of the heart and in that setting can actually preserve left ventricular function and result in an improvement in ejection fraction. Finally, cyclosporine, which was the principal immunosuppressive agent responsible for the vast increase in organ transplantation, has resulted in many patients undergoing heart transplantation safely that otherwise would never have received a heart. This chapter will review the positive and negative cardiac properties of the traditional antiinflammatory agents prednisone, azathioprine, methotrexate, cyclosporine, and cyclophosphamide.

AB - Antiinflammatory therapy is the principal therapy for most rheumatic diseases with the primary therapeutic goal being to reduce the destructive effects of the inflammatory process without causing systemic side effects due to overimmunosuppression. The heart is one of the primary organs affected by the side effects of these agents through both direct (myocardial injury) and indirect (hypertension, hyperlipidemia, etc.) actions that can result in myocardial injury in a number of different ways. Cyclophosphamide has direct cardiotoxic effects and can result in heart failure. Prednisone has secondary side effects including hypertension and hyperlipidemia, which can cause and/or accelerate coronary artery disease, and if a myocardial infarction happens can result in heart failure due to ischemic injury. Conversely, prednisone and other agents are often used for the therapy of inflammatory processes of the heart and in that setting can actually preserve left ventricular function and result in an improvement in ejection fraction. Finally, cyclosporine, which was the principal immunosuppressive agent responsible for the vast increase in organ transplantation, has resulted in many patients undergoing heart transplantation safely that otherwise would never have received a heart. This chapter will review the positive and negative cardiac properties of the traditional antiinflammatory agents prednisone, azathioprine, methotrexate, cyclosporine, and cyclophosphamide.

KW - Cardiovascular disease

KW - Immunosuppressive therapy

KW - Inflammation

KW - Myocarditis

KW - Side effects

UR - http://www.scopus.com/inward/record.url?scp=85020507018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020507018&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-803267-1.00026-0

DO - 10.1016/B978-0-12-803267-1.00026-0

M3 - Chapter

AN - SCOPUS:85020507018

SN - 9780128032671

SP - 645

EP - 657

BT - The Heart in Rheumatic, Autoimmune and Inflammatory Diseases

PB - Elsevier Inc.

ER -